medigraphic.com
Instituto Nacional de Salud Pública

2017, Número 3

<< Anterior Siguiente >>

salud publica mex 2017; 59 (3)


Invirtiendo en salud: el argumento económico. Informe del Foro sobre Inversión en Salud de la Cumbre Mundial sobre Innovación para la Salud 2016

Yamey G, Beyeler N, Wadge H, Jamison D

Idioma: Español
Referencias bibliográficas: 155
Paginas: 321-342
Archivo PDF: 763.00 Kb.


RESUMEN

Los gobiernos de los países en desarrollo y los organismos de ayuda internacional enfrentan decisiones difíciles en cuanto a la mejor manera de asignar sus recursos limitados. Las inversiones en distintos sectores –incluyendo educación, agua y saneamiento, transporte y salud– pueden generar beneficios sociales y económicos. Este informe se enfoca específicamente en el sector salud. Presenta evidencia contundente sobre el valor de ampliar las inversiones en salud. El argumento económico para incrementar estas inversiones en salud nunca ha sido más sólido. Con el progreso que se ha logrado en la reducción de la mortalidad materna e infantil y de las muertes por enfermedades infecciosas, es esencial que los responsables de la formulación de políticas no se vuelvan complacientes. Estos logros se revertirán rápidamente sin inversiones sostenidas en salud. Será necesario ampliar las inversiones para hacer frente a la carga generada por las enfermedades no transmisibles (ENT) emergentes y para alcanzar la cobertura universal de salud (CUS). El valor de la inversión en salud va mucho más allá de su rendimiento reflejado en la prosperidad económica a través del producto interno bruto (PIB). Las personas dan un gran valor monetario a los años de vida adicionales que las inversiones en salud pueden proporcionar –un valor inherente a permanecer con vida por más tiempo, que no tiene que ver con la productividad. Los encargados del diseño de políticas deben esforzarse más para asegurar que el gasto en salud refleje las prioridades de la gente. Para asegurar que los servicios sean accesibles para todos, la función del gobierno en el financiamiento de la salud es muy clara. Sin financiamiento público, habrá quienes no podrán costear los servicios que requieren y se verán forzados a elegir la enfermedad –o incluso la muerte– y la ruina económica, una elección devastadora que ya está llevando a 150 millones de personas a la pobreza cada año. En países de bajos ingresos (PBI) y países de ingresos medios (PIM), el financiamiento público debería ser utilizado para alcanzar la cobertura universal con un paquete de intervenciones altamente costo-efectivas (mejores inversiones u opciones). Los gobiernos que no protejan la salud y el patrimonio de su pueblo de esta manera serán incapaces de obtener los beneficios de una prosperidad económica y un crecimiento a largo plazo. El financiamiento público tiene el beneficio de ser más eficiente y capaz de controlar los costos que el financiamiento privado, y es la única manera sostenible de lograr una CUS. Además, la gente atribuye un alto valor económico a la protección que le provee el financiamiento público contra los riesgos financieros. Este informe aborda tres preguntas clave: 1) ¿Cuál es el fundamento económico para invertir en salud?; 2) ¿cuál es la mejor manera de financiar la salud?, y 3) ¿cuáles son las intervenciones que deben tener prioridad?


REFERENCIAS (EN ESTE ARTÍCULO)

  1. UN Inter-agency Group for Child Mortality Estimation. Levels and trends in child mortality [internet]. 2015. Disponible en: http://www.childmortality. org/files_v20/download/IGME%20report%202015%20child%20 mortality%20final.pdf

  2. World Health Organization. Global health observatory life expectancy data [internet]. Geneva: WHO, 2015. Disponible en: http://www.who.int/ gho/mortality_burden_disease/life_tables/en/

  3. Jamison DT, Summers LH, Alleyne G, Arrow KJ, Berkley S, Binagwaho A, et al. Global health 2035: a world converging within a generation. The Lancet 2013;382(9908):1898-955. https://doi.org/10.1016/S0140- 6736(13)62105-4

  4. Institute for Health Metrics and Evaluation. Financing global health 2014: Shifts in funding as the mdg era closes [internet]. Seattle: WA IHME, 2015. Disponible en: http://www.healthdata.org/policy-report/financing-globalhealth- 2014-shifts-funding-mdg-era-closes

  5. von Schoen-Angerer T, Ford N, Arkinstall J. Access to Medicines in Resource-limited Settings: The End of a Golden Decade? Glob Adv Health Med 2012;1(1):52-59. https://doi.org/10.7453/gahmj.2012.1.1.011

  6. The Lancet Editors. Global health in 2012: development to sustainability. The Lancet 2012;379(9812):193. https://doi.org/10.1016/S0140- 6736(12)60081-6

  7. Arrow KJ, Dasgupta P, Goulder LH, Mumford KJ, Oleson K. Sustainability and the measurement of wealth. Environ Dev Econ 2012;17(03):317-353. https://doi.org/10.1017/S1355770X12000137

  8. International Monetary Fund. World economic outlook: too slow for too long [internet]. Washington, D.: International Monetary Fund, 2016. Disponible en: http://www.imf.org/external/pubs/ft/weo/2016/01/pdf/text.pdf

  9. World Bank. World Development Report 1993: Investing in Health. New York: Oxford University Press, 1993. https://doi.org/10.1596/0-1952-0890-0

  10. United Nations Department of Economic and Social Affairs PD. World Population Prospects, the 2015 Revision [internet]. UN, 2015. Disponible en: http://esa.un.org/unpd/wpp/unpp

  11. Fink G, Rockers PC. Childhood growth, schooling, and cognitive development: further evidence from the Young Lives study. Am J Clin Nutr 2014;100(1):182-188. https://doi.org/10.3945/ajcn.113.080960

  12. Meng X, Qian N. The long term consequences of famine on survivors: evidence from a unique natural experiment using China’s great famine Report No.: 14917. [internet]. National Bureau of Economic Research. 2009 [cited 2016 Feb 8]. Disponible en: http://www.nber.org/papers/w14917

  13. Umana-Aponte M. Long-term effects of a nutritional shock: the 1980 famine of Karamoja, Uganda [Internet]. UK: Department of Economics, University of Bristol, 2011 [cited Feb 12, 2016]. Report No. 11/258. Disponible en: https://ideas.repec.org/p/bri/cmpowp/11-258.html

  14. Hoddinott J, Behrman JR, Maluccio JA, Melgar P, Quisumbing AR, Ramirez-Zea M, et al. Adult consequences of growth failure in early childhood. Am J Clin Nutr 2013;98(5):1170-1178 https://doi.org/10.3945/ ajcn.113.064584

  15. Victora CG, Adair L, Fall C, Hallal PC, Martorell R, Richter L, et al. Maternal and child undernutrition: consequences for adult health and human capital. The Lancet 2008;371(9609):340-357. https://doi.org/10.1016/ S0140-6736(07)61692-4

  16. Chen Y, Zhou LA. The long-term health and economic consequences of the 1959–1961 famine in China. J Health Econ 2007;26(4):659-681. https://doi.org/10.1016/j.jhealeco.2006.12.006

  17. Fernando SD, Rodrigo C, Rajapakse S. The “hidden” burden of malaria: cognitive impairment following infection. Malar J 2010;9(1):1-11. https:// doi.org/10.1186/1475-2875-9-366

  18. Venkataramani AS. Early life exposure to malaria and cognition in adulthood: evidence from Mexico. J Health Econ 2012;31(5):767-780. https://doi.org/10.1016/j.jhealeco.2012.06.003

  19. Barofsky J, Anekwe TD, Chase C. Malaria eradication and economic outcomes in sub-Saharan Africa: evidence from Uganda. J Health Econ 2015;44:118-136. https://doi.org/10.1016/j.jhealeco.2015.08.002

  20. Currie J, Vogl T. Early-life health and adult circumstance in developing countries. Annu Rev Econ 2013;5:1-36. https://doi.org/10.1146/annureveconomics- 081412-103704

  21. Currie J, Zivin JSG, Mullins J, Neidell MJ. What do we know about short and long term effects of early life exposure to pollution? Report No. 19571. [internet]. National Bureau of Economic Research, 2013 [cited 2016 Mar 16]. Disponible en: http://www.nber.org/papers/w19571

  22. Walker SP, Wachs TD, Grantham-McGregor S, Black MM, Nelson CA, Huffman SL, et al. Inequality in early childhood: risk and protective factors for early child development. Lancet 2011;378(9799):1325-1338. https:// doi.org/10.1016/S0140-6736(11)60555-2

  23. Vogl T. Education and Health in Developing Economies [internet]. New Jersey: Princeton University and NBER, 2012. Disponible en: www. princeton.edu/~tvogl/vogl_ed_health_review.pdf

  24. Daniels MC, Adair LS. Growth in young Filipino children predicts schooling trajectories through high school. J Nutr 2004;134(6):1439-1446.

  25. Alderman H, Hoddinott J, Kinsey B. Long term consequences of early childhood malnutrition. Oxf Econ Pap 2006 Jul 1;58(3):450-474. https:// doi.org/10.1093/oep/gpl008

  26. Almond D, Currie J. Killing Me Softly: The Fetal Origins Hypothesis. J Econ Perspect J Am Econ Assoc 2011;25(3):153-172. https://doi. org/10.1257/jep.25.3.153

  27. Thomas D, Frankenberg E. Health, nutrition and prosperity: a microeconomic perspective. Bull World Health Organ 2002;80(2):106-113.

  28. Field E, Robles O, Torero M. Iodine Deficiency and Schooling Attainment in Tanzania. Am Econ J Appl Econ 2009;1(4):140-169. https://doi. org/10.1257/app.1.4.140

  29. Stein AD, Wang M, DiGirolamo A, Grajeda R, Ramakrishnan U, Ramirez-Zea M, et al. Nutritional supplementation in early childhood, schooling, and intellectual functioning in adulthood: a prospective study in Guatemala. Arch Pediatr Adolesc Med 2008;162(7):612-618. https://doi. org/10.1001/archpedi.162.7.612

  30. Hoddinott J, Maluccio JA, Behrman JR, Flores R, Martorell R. Effect of a nutrition intervention during early childhood on economic productivity in Guatemalan adults. Lancet 2008;371(9610):411-416. https://doi. org/10.1016/S0140-6736(08)60205-6

  31. Maluccio JA, Hoddinott J, Behrman JR, Martorell R, Quisumbing AR, Stein AD. The Impact of Improving Nutrition During Early Childhood on Education among Guatemalan Adults. Econ J 2009;119(537):734-763. https://doi.org/10.1111/j.1468-0297.2009.02220.x

  32. Crookston BT, Penny ME, Alder SC, Dickerson TT, Merrill RM, Stanford JB, et al. Children who recover from early stunting and children who are not stunted demonstrate similar levels of cognition. J Nutr 2010;140(11):1996-2001. https://doi.org/10.3945/jn.109.118927

  33. Cutler D, Fung W, Kremer M, Singhal M, Vogl T. Mosquitoes: the longterm effects of malaria eradication in India Report No. 13539. [internet]. National Bureau of Economic Research, 2007 [cited 2016 Mar 16]. Disponible en: http://www.nber.org/papers/w13539

  34. Canning D, Razzaque A, Driessen J, Walker DG, Streatfield PK, Yunus M. The effect of maternal tetanus immunization on children’s schooling attainment in Matlab, Bangladesh: follow-up of a randomized trial. Soc Sci Med 2011;72(9):1429-1436. https://doi.org/10.1016/j.socscimed. 2011.02.043

  35. Bloom DE, Canning D, Shenoy ES. The effect of vaccination on children’s physical and cognitive development in the Philippines. Appl Econ 2012;44(21):2777-2783. https://doi.org/10.1080/00036846.2011.566203

  36. Deogaonkar R, Hutubessy R, van der Putten I, Evers S, Jit M. Systematic review of studies evaluating the broader economic impact of vaccination in low and middle income countries. BMC Public Health 2012;12:878. http://doi.org/10.1186/1471-2458-12-878

  37. Jit M, Hutubessy R, Png ME, Sundaram N, Audimulam J, Salim S, et al. The broader economic impact of vaccination: reviewing and appraising the strength of evidence. BMC Med 2015;13:209. https://doi.org/10.1186/ s12916-015-0446-9

  38. Driessen J, Razzaque A, Walker D, Canning D. The effect of childhood measles vaccination on school enrolment in Matlab, Bangladesh. Appl Econ 2015;47(55):6019-6040. https://doi.org/10.1080/00036846.2015.1061647

  39. Anekwe TD, Newell M-L, Tanser F, Pillay D, Bärnighausen T. The causal effect of childhood measles vaccination on educational attainment: a mother fixed-effects study in rural South Africa. Vaccine 2015;33(38):5020- 5026. https://doi.org/10.1016/j.vaccine.2015.04.072

  40. Bleakley H. Disease and Development: Evidence from Hookworm Eradication in the American South Q J Econ 2007;122(1):73-117. https:// doi.org/10.1162/qjec.121.1.73

  41. Taylor-Robinson DC, Maayan N, Soares-Weiser K, Donegan S, Garner P. Deworming drugs for soil-transmitted intestinal worms in children: effects on nutritional indicators, haemoglobin and school performance. Cochrane Database Syst Rev 2012;7:CD000371. https://doi. org/10.1002/14651858.cd000371.pub5

  42. Davey C, Aiken AM, Hayes RJ, Hargreaves JR. Re-analysis of health and educational impacts of a school-based deworming programme in western Kenya: a statistical replication of a cluster quasi-randomized steppedwedge trial. Int J Epidemiol 2015;44(5):1581-1592. https://doi.org/10.1093/ ije/dyv128

  43. Zivin JSG, Neidell MJ. The impact of pollution on worker productivity Report No. 17004. [internet]. National Bureau of Economic Research 2011 [cited 2016 Mar 16]. Disponible en: http://www.nber.org/papers/ w17004

  44. Fox MP, Rosen S, MacLeod WB, Wasunna M, Bii M, Foglia G, et al. The impact of HIV/AIDS on labour productivity in Kenya. Trop Med Int Health TM IH 2004;9(3):318-324. https://doi.org/10.1111/j.1365- 3156.2004.01207.x

  45. Habyarimana J, Mbakile B, Pop-Eleches C. The Impact of HIV/AIDS and ARV Treatment on Worker Absenteeism Implications for African Firms. J Hum Resour 2010;45(4):809-839. https://doi.org/10.1353/jhr.2010.0032

  46. Levinsohn JA, McLaren Z, Shisana O, Zuma K. HIV Status and Labor Market Participation in South Africa Report No. 16901. [internet]. National Bureau of Economic Research, 2011 [cited 2016 Mar 18]. Disponible en: http://www.nber.org/papers/w16901

  47. Chima RI, Goodman CA, Mills A. The economic impact of malaria in Africa: a critical review of the evidence. Health Policy 2003;63(1):17-36. https://doi.org/10.1016/S0168-8510(02)00036-2

  48. Alam K, Mahal A. Economic impacts of health shocks on households in low and middle income countries: a review of the literature. Glob Health 2014;10:21. https://doi.org/10.1186/1744-8603-10-21

  49. Xu K, Evans DB, Carrin G, Aguilar-Rivera AM, Musgrove P, Evans T. Protecting households from catastrophic health spending. Health Aff Proj Hope 2007;26(4):972-983. https://doi.org/10.1377/hlthaff.26.4.972

  50. Bachmann MO, Booysen FL. Health and economic impact of HIV/ AIDS on South African households: a cohort study. BMC Public Health 2003;3:14. https://doi.org/10.1186/1471-2458-3-14

  51. Ettling M, McFarland DA, Schultz LJ, Chitsulo L. Economic impact of malaria in Malawian households. Trop Med Parasitol 1994;45(1):74-79.

  52. Jaspers L, Colpani V, Chaker L, ven der Lee S, Muka T, Imo D. The global impact of non-communicable diseases on households and impoverishment: a systematic review. Eur J Epidemiol 2015;30:163-188. https://doi. org/10.1007/s10654-014-9983-3

  53. Engelgau MM, Karan A, Mahal A. The Economic impact of Non-communicable Diseases on households in India. Glob Health 2012;8:9. https://doi. org/10.1186/1744-8603-8-9

  54. Karan A, Engelgau M, Mahal A. The household-level economic burden of heart disease in India. Trop Med Int Health 2014;19(5):581-591. https:// doi.org/10.1111/tmi.12281

  55. Counts CJ, Skordis-Worrall J. Recognizing the importance of chronic disease in driving healthcare expenditure in Tanzania: analysis of panel data from 1991 to 2010. Health Policy Plan 2016;31(4):434-443. https://doi. org/10.1093/heapol/czv081

  56. Kankeu H, Saksena P, Xu K, Evans D. The financial burden from noncommunicable diseases in low- and middle-income countries: a literature review. Health Res Policy Syst 2013;11:31. https://doi.org/10.1186/1478- 4505-11-31

  57. Heltberg R, Oviedo AM, Talukdar F. What do Household Surveys Really Tell Us about Risk, Shocks, and Risk Management in the Developing World? J Dev Stud 2015;51(3):209-225.

  58. Dhanaraj S. Economic vulnerability to health shocks and coping strategies: evidence from Andhra Pradesh, India. Health Policy Plan 2016;czv127. https://doi.org/10.1093/heapol/czv127

  59. van Doorslaer E, O’Donnell O, Rannan-Eliya RP, Somanathan A, Adhikari SR, Garg CC, et al. Effect of payments for health care on poverty estimates in 11 countries in Asia: an analysis of household survey data. Lancet 2006;368(9544):1357-1364. https://doi.org/10.1016/S0140- 6736(06)69560-3

  60. Thirumurthy H, Galárraga O, Larson B, Rosen S. HIV Treatment produces economic returns through increased work and education, and warrants continued US support. Health Aff 2012;31(7):1470-1477. https:// doi.org/10.1377/hlthaff.2012.0217

  61. Rosen S, Larson B, Rohr J, Sanne I, Mongwenyana C, Brennan AT, et al. Effect of antiretroviral therapy on patients’ economic well being: five-year follow-up. AIDS 2014;28(3):417-424. https://doi.org/10.1097/ QAD.0000000000000053

  62. Basta SS, Soekirman null, Karyadi D, Scrimshaw NS. Iron deficiency anemia and the productivity of adult males in Indonesia. Am J Clin Nutr 1979;32(4):916-925.

  63. Isen A, Rossin-Slater M, Walker R. Every breath you take - every dollar you’ll make: the long-term consequences of the Clean Air Act of 1970. NBER Work Pap No. 19858; 2014.

  64. Walker SP, Chang SM, Wright A, Osmond C, Grantham-McGregor SM. Early Childhood Stunting Is Associated with Lower Developmental Levels in the Subsequent Generation of Children. J Nutr 2015;145(4):823-828. https://doi.org/10.3945/jn.114.200261

  65. Stein AD, Barnhart HX, Hickey M, Ramakrishnan U, Schroeder DG, Martorell R. Prospective study of protein-energy supplementation early in life and of growth in the subsequent generation in Guatemala. Am J Clin Nutr. 2003;78(1):162–7.

  66. Behrman JR, Calderon MC, Preston SH, Hoddinott J, Martorell R, Stein AD. Nutritional supplementation in girls influences the growth of their children: prospective study in Guatemala. Am J Clin Nutr 2009;90(5):1372- 1379. https://doi.org/10.3945/ajcn.2009.27524

  67. Liu G, Hackney C, Yao Y. Health and wealth: the role of health in economic growth. Working Paper, China Center for Health Economics Research. China: Peking University, 2016.

  68. Jamison DT, Lau L, Wang J. Health’s contribution to economic growth in an environment of partially endogenous technical progress. In: Health and economic growth: findings and policy implications. Cambridge, MA: MIT Press, 2005:67-91.

  69. Okorosobo T, Okorosobo F, Mwabu G, Orem J, Kirigia J. Economic burden of malaria in six countries of Africa. Eur J Bus Manag 2011;3(6).

  70. Purdy M, Robinson M, Wei K, Rublin D. The Economic Case for Combating Malaria. Am J Trop Med Hyg 2013;89(5):819-823. https://doi. org/10.4269/ajtmh.12-0689

  71. Roll Back Malaria. Global Malaria Action Plan for a Malaria-Free World [internet]. 2008. Disponible en: http://www.rollbackmalaria.org/microsites/ gmap/toc.html

  72. Stack ML, Ozawa S, Bishai DM, Mirelman A, Tam Y, Niessen L, et al. Estimated economic benefits during the “decade of vaccines” include treatment savings, gains in labor productivity. Health Aff 2011;30(6):1021- 1028. https://doi.org/10.1377/hlthaff.2011.0382

  73. Stenberg K, Axelson H, Sheehan P, Anderson I, Gülmezoglu AM, Temmerman M, et al. Advancing social and economic development by investing in women’s and children’s health: a new Global Investment Framework. Lancet 2014;383(9925):1333-1354. https://doi.org/10.1016/ S0140-6736(13)62231-X

  74. Baicker K, Chandra A. The health care jobs fallacy. N Engl J Med 2012;366(26):2433-2435. https://doi.org/10.1056/NEJMp1204891

  75. Baumol W. The cost disease: why computers get cheaper and health care doesn’t. New Haven: Yale University Press, 2012.

  76. Baumol WJ. Macroeconomics of unbalanced growth: the anatomy of urban crisis. Am Econ Rev 1967;57(3):415-426.

  77. Evans T, Soucat A. Economic, demographic, and epidemiological transitions and the future of health labor markets. Global Health Workforce Alliance, Working Group Paper, 2015.

  78. Hartwig J. What drives health care expenditure?—Baumol’s model of “unbalanced growth” revisited. J Health Econ 2008;27(3):603-623. https:// doi.org/10.1016/j.jhealeco.2007.05.006

  79. Hartwig J. Can Baumol’s model of unbalanced growth contribute to explaining the secular rise in health care expenditure? An alternative test. Appl Econ 2011;43(2):173-184. https://doi. org/10.1080/00036840802400470

  80. World Health Organization. Health workforce: presidents Hollande and Zuma chair the first meeting of the High-Level Commission on Health Employment and Economic Growth [internet]. 2016. Disponible en: http://www.who.int/hrh/com-heeg/com-heeg-meeting-chair/en/

  81. Bloom DE, Canning D, Jamison DT. Health, wealth, and welfare. Finance Dev 2004;41:110-115.

  82. Bloom DE, Canning D. Policy forum: public health. The health and wealth of nations. Science 2000;287(5456):1207-1209. https://doi. org/10.1126/science.287.5456.1207

  83. Gallup JL, Sachs JD. The economic burden of malaria. Am J Trop Med Hyg 2001;64(Suppl 1):85-96.

  84. Lee R, Mason A. What is the demographic dividend? Finance & Development 2006;43(3).

  85. Bloom D, Cafiero-Fonseca ET, McGovern M, Prettner K, Stanciole AE, Weiss J, et al. The macroeconomic impact of non-communicable diseases in China and India: estimates, projections, and comparisons. J Econ Ageing 2014;4:100-111. https://doi.org/10.1016/j.jeoa.2014.08.003

  86. Chi S, Lee S, Liu G, Jamison DT. Evolution of the value of longevity in China. Working Paper 2016.

  87. Becker GS, Philipson TJ, Soares RR. The quantity and quality of life and the evolution of world inequality. Am Econ Rev 2005;95(1):277-291. https://doi.org/10.1257/0002828053828563

  88. Chang A. What is a life year worth? Sensitivity of the Lancet Commission on Investing in Health estimates to underlying assumptions and implications. Washington DC, 2016.

  89. Consejo Nacional de Población. Mexican Population Projections 2010- 2050 [internet]. México: Conapo, 2014. Disponible en: http://www.conapo. gob.mx/es/CONAPO/Proyecciones

  90. Instituto Nacional de Estadística y Geografía. Statistics of mortality 1990-2014 [internet]. México: Inegi, 2016. Disponible en: http://www.inegi. org.mx/est/lista_cubos/consulta.aspx?p=adm&c=4

  91. OECD. Health at a glance 2015: OECD Indicators [internet]. Paris: OECD, 2015. https://doi.org/10.1787/health_glance-2015-en

  92. Secretaría de Salud, Mexico. Dirección General de Información en Salud [internet]. México: SSa, 2015. Disponible en: http://www.dgis.salud. gob.mx/contenidos/sinais/s_index.html

  93. Sansores D, Gutierrez D. Financing Impact of Overweight and Obesity in Mexico, 1999-2023. Mexico: SSa, 2015.

  94. Baicker K, Goldman D. Patient Cost-Sharing and Healthcare Spending Growth. J Econ Perspect 2011;25(2):47-68. https://doi.org/10.1257/ jep.25.2.47

  95. Kruk ME, Goldmann E, Galea S. Borrowing and selling to pay for health care in low- and middle-income countries. Health Aff Proj Hope 2009;28(4):1056-1066. https://doi.org/10.1377/hlthaff.28.4.1056

  96. Nicholson D, Yates R, Warburton W, Fontana G. Delivering universal health coverage: a guide for policymakers. Report of the WISH Universal Health Coverage Forum, 2015.

  97. Potetz L, Cubanski J, Neuman T. Medicare spending and financing: a primer. The Henry J Kaiser Family Foundation, 2011. Disponible en: https:// kaiserfamilyfoundation.files.wordpress.com/2013/01/7731-03.pdf

  98. Merlis M. Simplifying administration of health insurance. National Academy of Social Insurance, National Academy of Public Administration, Robert Wood Johnson Foundation, 2009.

  99. WHO. Administrative Costs of Health Insurance Schemes: Exploring the Reasons for Their Variability. Geneva: WHO 2010.

  100. Central Office of Information. The New National Health Service. London: Central Office of Information, 1948.

  101. Finkelstein A, McKnight R. What did Medicare do (and was it worth it)? Report No. 11609. [internet]. National Bureau of Economic Research, 2005 [cited 2016 Mar 23]. Disponible en: http://www.nber.org/papers/ w11609

  102. Giedion U, Alfonso EA, Diaz Y. The impact of universal coverage schemes in the developing world: a review of the existing evidence Report No. 75326. [internet]. The World Bank, 2013 [cited 2016 Mar 23]. Disponible en: http://documents.worldbank.org/curated/en/2013/01/17291221/ impact-universal-coverage-schemes-developing-world-review-existingevidence

  103. Shrime M, Verguet S, Johansson K, Desalegn D, Jamison D, Kruk ME. Task-sharing or public finance for expanding surgical access in rural Ethiopia: an extended cost-effectiveness analysis. In: Essential surgery: disease control priorities. Third Edition (vol 1). Washington DC: The International Bank for Reconstuction and Development/The World Bank, 2015:339-352. https://doi.org/10.1596/978-1-4648-0346-8_ch19

  104. Yip WC-M, Hsiao WC, Chen W, Hu S, Ma J, Maynard A. Early appraisal of China’s huge and complex health-care reforms. Lancet 2012;379(9818):833-842. https://doi.org/10.1016/S0140-6736(11)61880-1

  105. Jha P, Joseph R, Li D, Gauvreau C, Anderson I, Moser P, et al. Tobacco taxes: a win-win measure for fiscal space and health. Mandaluyong City, Philippines: Asian Development Bank, 2012.

  106. Salti N, Chaaban J, Naamani N. The economics of tobacco in Lebanon: an estimation of the social costs of tobacco consumption. Subst Use Misuse 2014;49(6):735-742. https://doi.org/10.3109/10826084.2013.863937

  107. Salti N. On the progressivity of increasing taxes on tobacco: an extended cost effectiveness analysis for Lebanon. 2014. Disponible en: http://bit.ly/1UgnMpL

  108. Verguet S, Gauvreau CL, Mishra S, MacLennan M, Murphy SM, Brouwer ED, et al. The consequences of tobacco tax on household health and finances in rich and poor smokers in China: an extended cost-effectiveness analysis. Lancet Glob Health 2015;3(4):e206-e216. https://doi. org/10.1016/S2214-109X(15)70095-1

  109. Limwattananon S, Neelsen S, O’Donnell OA, Prakongsai P, Tangcharoensathien V, Doorslaer V, et al. Universal coverage on a budget: impacts on health care utilization and out-of-pocket expenditures in Thailand Report No. ID 2277437. [internet]. Rochester, NY: Social Science Research Network, 2013 [cited 2016 Mar 3]. Disponible en: http://papers.ssrn.com/ abstract=2277437

  110. Finkelstein A, Hendren N, Luttmer EFP. The Value of Medicaid: interpreting results from the Oregon Health Insurance Experiment Report No. 21308. [internet]. National Bureau of Economic Research, 2015 [cited 2016 Mar 3]. Disponible en: http://www.nber.org/papers/w21308

  111. Neyfakh L. Is health insurance an antidepressant? [internet]. Boston Globe, 2013 [cited 2016 Mar 3]. Disponible en: https://www.bostonglobe. com/ideas/2013/06/23/health-insurance-antidepressant/bn3cq4XTH67RMZ9b3i0R7M/ story.html

  112. Stabile M, Thomson S, Allin S, Boyle S, Busse R, Chevreul K, et al. Health care cost containment strategies used in four other high-income countries hold lessons for the United States. Health Aff Proj Hope 2013;32(4):643-652. https://doi.org/10.1377/hlthaff.2012.1252

  113. World Health Organization. World Health Report 2010: Health Systems Financing: The Path to Universal Coverage. Geneva: WHO, 2010.

  114. Coady D, Parry I, Sears L, Shang B. How large are global energy subsidies? Report No. Working paper No. 15/105. Washington DC: International Monetary Fund, 2015.

  115. Easterly W. The white man’s burden: why the west’s efforts to Aid the rest have done so much ill and so little good. New York: Penguin Press, 2006.

  116. Moyo D. Dead Aid: why aid is not working and how there is a better way for Africa. New York: Farrar, Straus and Giroux, 2009.

  117. Deaton A. The Great escape: health, wealth, and the origins of inequality. Princeton, New Jersey: Princeton University Press, 2013.

  118. Flaxman AD, Fullman N, Jr MWO, Menon M, Cibulskis RE, Ng M, et al. Rapid scaling up of insecticide-treated bed net coverage in Africa and its relationship with development assistance for health: a systematic synthesis of supply, distribution, and household survey data. PLOS Med 2010;7(8):e1000328. https://doi.org/10.1371/journal.pmed.1000328

  119. Lim SS, Fullman N, Stokes A, Ravishankar N, Masiye F, Murray CJL, et al. Net benefits: a multicountry analysis of observational data examining associations between insecticide-treated mosquito nets and health outcomes. PLOS Med 2011;8(9):e1001091. https://doi.org/10.1371/journal. pmed.1001091

  120. Mills A, Shillcutt S. The challenge of communicable disease. In: Global crises, global solutions. Cambridge: Cambridge University Press, 2004. https://doi.org/10.1017/CBO9780511492624.003

  121. Bendavid E, Holmes CB, Bhattacharya J, Miller G. HIV development assistance and adult mortality in africa. JAMA 2012;307(19):2060-2067. https://doi.org/10.1001/jama.2012.2001

  122. Perry R, Murray J, Gacic-Dobo M, Dabbagh A, Mulders M, Strebel P, et al. Progress toward regional measles elimination - worldwide, 2000 - 2014. Morb Mortal Wkly Rep 2015;64(44):1246-1251. https://doi.org/10.15585/ mmwr.6444a4

  123. Bendavid E, Bhattacharya J. The relationship of health aid to population health improvements. JAMA Intern Med 2014;174(6):881-887. https:// doi.org/10.1001/jamainternmed.2014.292

  124. Center for Global Development. Millions Saved [internet]. Disponible en: http://millionssaved.cgdev.org/

  125. Copenhagen Consensus. Outcome: expert panel findings, Copenhagen Consensus outcome paper. 2012. Disponible en: http://www.copenhagenconsensus. com/copenhagen-consensus-iii/outcome

  126. Schäferhoff M, Fewer S, Kraus J, Richter E, Summers LH, Sundewall J, et al. How much donor financing for health is channelled to global versus country-specific aid functions? Lancet 2015;386(10011):2436-2441. https://doi.org/10.1016/S0140-6736(15)61161-8

  127. Davies D, Verde E. Antimicrobial resistance: in search of a collaborative solution [internet]. Qatar: World Innovation Summit for Health, 2013 [cited 2016 Mar 3]. Disponible en: http://cdn.wish.org.qa/app/media/385

  128. Hecht R, Jamison DT. Vaccine research and development assessment paper. In: Rethink HIV: smarter ways to invest in ending HIV in Sub-Saharan Africa. New York: Cambridge University Press, 2012:299-320. https:// doi.org/10.1017/CBO9781139236805.009

  129. Lakdawalla D, Malani A, Reif J. The insurance value of medical innovation. NBER Working Paper, 2015.

  130. World Bank. Pandemic risk and one health [internet]. Washington, DC: World Bank, 2013 [cited 2016 Mar 3]. Disponible en: http://www. worldbank.org/en/topic/health/brief/pandemic-risk-one-health

  131. Sands P. The neglected dimension of global security: a framework to consider infectious disease crises. Washington DC: National Academies Press, 2016.

  132. Fan V, Jamison DT, Summers LH. The inclusive cost of pandemic influenza risk. Cambridge: National Bureau of Economic Research, 2016. NBER Working Paper.

  133. Davis K. The amazing decline of mortality in underdeveloped areas. Am Econ Rev 1956;46(2):305-318.

  134. Croghan TW, Beatty A, Ron A. Routes to better health for children in four developing countries. Milbank Q 2006;84(2):333-358. https://doi. org/10.1111/j.1468-0009.2006.00450.x

  135. World Innovation Summit for Health Forum on Precision Medicine [internet]. Qatar: World Innovation Summit for Health, 2016 [cited 2016 Mar 3]. Disponible en: http://wish-qatar.org/media-center/press-releasedetails? item=176&backArt=71

  136. Jamison DT, Murphy SM, Sandbu ME. Why has under-5 mortality decreased at such different rates in different countries? J Health Econ 2016;48:16-25. https://doi.org/10.1016/j.jhealeco.2016.03.002

  137. World Health Organization. World Health Report 1999: Making a Difference. Geneva: WHO, 1999.

  138. Disease Control Priorities. Disease Control Priorities [internet]. Disponible en: http://www.dcp-3.org/

  139. Cleason M, Mawji T, Walker C. Investing in the best buys: a review of the health, nutrition, and population portfolio, FY 1993-1999. Health, Nutrition and Population Discussion Paper [internet]. Washington DC: World Bank, 2000 [cited 2016 Mar 3]. Disponible en: http://siteresources. worldbank.org/

  140. Ozawa S, Mirelman A, Stack ML, Walker DG, Levine OS. Cost-effectiveness and economic benefits of vaccines in low- and middle-income countries: a systematic review. Vaccine 2012;31(1):96-108. https://doi. org/10.1016/j.vaccine.2012.10.103

  141. Hoddinott J, Alderman H, Behrman JR, Haddad L, Horton S. The economic rationale for investing in stunting reduction. Matern Child Nutr 2013;9:69-82. https://doi.org/10.1111/mcn.12080

  142. Nugent RA. Benefits and costs of the non-communicable disease targets for the post-2015 development agenda. Post-2015 Consens [internet]. Disponible en: http://dcp-3.org/sites/default/files/resources/R%20 Nugent%20CC%20Perspective%20Paper.pdf

  143. Verguet S, Laxminarayan R, Jamison DT. Universal Public Finance of Tuberculosis Treatment in India: an extended cost-effectiveness analysis. Health Econ 2015;24(3):318-332. https://doi.org/10.1002/hec.3019

  144. Verguet S, Murphy S, Anderson B, Johansson KA, Glass R, Rheingans R. Public finance of rotavirus vaccination in India and Ethiopia: an extended cost-effectiveness analysis. Vaccine 2013;31(42):4902-4910. https://doi. org/10.1016/j.vaccine.2013.07.014

  145. Bloom D, Chisolm D, Jane-Lopis E, Prettner K, Stein A, Feigl A. From Burden to “best buys”: reducing the economic impact of non-communicable diseases in low- and middle-income countries. World Economic Forum, 2011.

  146. Ministry of Health, Federal Democratic Republic of Ethiopia. National Mental Health Strategy 2012/13 - 2015/16. Ethiopia: Ministry of Health, 2012.

  147. World Innovation Summit for Health Forum on Cardiovascular Disease [internet]. Qatar: world innovation summit for health, 2016. Disponible en: http://wish-qatar.org/media-center/press-releasedetails? item=180&backArt=71

  148. World Health Organization. Global Health Expenditure Database, 2013. Geneva: WHO,2013.

  149. International Monetary Fund. World Economic Prospects. Washington DC: International Monetary Fund, 2015.

  150. Emery N. Rwanda’s historic health recovery: what the U.S. might learn. The Atlantic [internet]. 2013 [cited 2016 Mar 3]. Disponible en: http://www.theatlantic.com/health/archive/2013/02/rwandas-historichealth- recovery-what-the-us-might-learn/273226/

  151. Farmer PE, Nutt CT, Wagner CM, Sekabaraga C, Nuthulaganti T, Weigel JL, et al. Reduced premature mortality in Rwanda: lessons from success. BMJ 2013;346:f65. https://doi.org/10.1136/bmj.f65

  152. McNeil Jr D. Rwanda’s health care success story. The New York Times [internet]. 2013 Feb 4. Disponible en: http://www.nytimes. com/2013/02/05/science/rwandas-health-care-success-story.html?_r=0

  153. National Institute of Statistics of Rwanda. Integrated household living conditions survey 3 (EICV 3) [Internet]. Rwanda: National Institute of Statistics of Rwanda, 2012 [cited 2016 Mar 3]. Disponible en: http://www. statistics.gov.rw/survey-period/integrated-household-living-conditionssurvey- 3-eicv-3

  154. World Bank. World Development Indicators [internet]. Washington, DC: World Bank, 2015 [cited 2016 Mar 3]. Disponible en: http://data. worldbank.org/data-catalog/world-development-indicators

  155. World Health Organization. World Malaria Report: 2012 [internet]. Geneva: WHO, 2012 [cited 2016 Mar 3]. Disponible en: http://www.who. int/malaria/publications/world_malaria_report_2012/wmr2012_no_profiles. pdf?ua=1




2020     |     www.medigraphic.com